Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea flag South Korea · Delayed Price · Currency is KRW
91,500
+3,200 (3.62%)
Jul 7, 2026, 2:05 PM KST

Kolon TissueGene Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,502,8656,624,4131,847,594655,804612,433518,608
Market Cap Growth
129.86%258.54%181.73%7.08%18.09%5.93%
Enterprise Value
7,445,7676,582,6781,835,745610,221540,002508,454
Last Close Price
88300.0079600.0023250.009020.008890.008010.00
PS Ratio
1420.741284.12364.17176.9564.77129.55
PB Ratio
60.10103.3812.665.706.6913.42
P/TBV Ratio
60.21103.6712.685.716.7113.49
EV/Sales Ratio
-1276.03361.84164.6657.11127.01
Debt / Equity Ratio
0.521.240.120.060.080.19
Net Debt / Equity Ratio
-0.46-0.040.11-0.18-0.56-0.82
Net Debt / EBITDA Ratio
2.660.12-0.781.103.500.70
Net Debt / FCF Ratio
4.560.10-0.800.861.910.78
Asset Turnover
0.010.020.030.030.110.06
Inventory Turnover
109.7359.0457.4282.6419.3514.10
Quick Ratio
0.320.230.022.015.082.44
Current Ratio
0.330.240.102.245.442.69
Return on Equity (ROE)
-185.81%-183.43%-25.91%-16.69%-17.11%-109.20%
Return on Assets (ROA)
-3.40%-4.32%-7.70%-10.47%-11.90%-43.86%
Return on Capital Employed (ROCE)
-17.30%-32.70%-14.60%-17.00%-16.60%-104.10%
Earnings Yield
-3.82%-2.91%-1.83%-2.63%-1.82%-9.13%
FCF Yield
-0.17%-0.38%-1.11%-3.72%-4.38%-7.82%
Buyback Yield / Dilution
-5.95%-6.78%-7.32%-8.18%-8.25%-0.29%